RCS — Arecor Therapeutics — Patents for concentrated ultra — rapid insulins
For best results when printing this announcement, please click on link below: RNS Number: 9983Y Arecor Therapeutics PLC 15 October 2026 Arecor Therapeutics plc ("Arecor", the "Company" or the "Group") Expanded international IP protection for concentrated ultra-rapid acting insulins enabling next generation of Automated